Amazon is reportedly in talks to buy Covington’s Globalstar for about $9 billion, a move that would accelerate its low‑Earth‑orbit plans and is complicated by Apple’s 20% stake.

An Oakwood Village woman says a Cleveland Clinic gene‑editing trial has cut years of sickle‑cell pain and hospital visits. Early results from the RUBY study show promising improvements for participants.

A Lumina–Gallup study finds 47% of students have seriously considered changing majors because of AI, while 57% use AI weekly and many campus policies remain unclear.

UC San Diego researchers say the protein TYK2 helps keep early breast tumors from invading. Lab tests found TYK2‑blocking drugs increased tumor spread in mice, prompting clinical caution.

Stockton native José Hernández used the Artemis II launch to urge local students toward STEM and spotlight the outreach programs he runs back home. His foundation and school partnerships deliver hands‑on science to Central Valley youth.

A Christ Hospital pilot found an AI virtual assistant could speed guideline‑directed therapy and reduce short‑term hospitalizations for new heart‑failure patients.

Johns Hopkins used patient-specific "digital twins" of diseased hearts to plan VT ablations; early results kept eight of ten patients free of arrhythmia after more than a year.

New reports show AI exposure for 240,000 Richmond jobs and steep drops in entry-level tech postings that could squeeze young workers.

Anthropic accidentally pushed a debug file that exposed roughly 512,000 lines of Claude Code to the public; the company says no customer data or credentials were exposed.

An Ohio State study using objective lab tests of 60 adults finds long COVID often causes measurable smell, hearing, balance and cognitive problems, with age and severe illness linked to worse outcomes.

Salk's La Jolla team released a cloud-hosted atlas that charts how brain cells change with age. The open dataset aims to speed Alzheimer's and Parkinson's research.

Mid‑America Transplant has begun flying donor blood samples along a new Missouri drone corridor, trimming delivery time and costs while testing a Rolla hub. Partners say the route could improve access for rural hospitals.

Korsana will take Cyclerion’s Nasdaq listing through an all‑stock reverse merger backed by about $380M, giving the startup cash into 2029 and a faster route to 2027 readouts. The combined company will trade as KRSA.